NCT03086993 2022-03-24
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Delcath Systems Inc.
Phase 2/3 Unknown
Delcath Systems Inc.
Centre Hospitalier Universitaire de Saint Etienne
ASLAN Pharmaceuticals
Weill Medical College of Cornell University
Federation Francophone de Cancerologie Digestive